Created at Source Raw Value Validated value
June 25, 2024, noon usa

inclusion criteria: 1.patients diagnosed clinically or by rt-pcr in nasopharyngeal swab specimens and/ or lung involvement confirm by computed tomography scan compatible with covid-19patients 2.age between 18 year and 70 years, 3.body weight \> 50 kg, 4.with written informed consent from patients or relatives. - exclusion criteria 1 sensitivity to any medications of regimens, 2.e gfr less than 30. 3.pregnancy. 4.malignancy . 5.participating in another clinical study and refusing to participate in the study at a later date or later, and they are already taking colchicine for other diseases . -

inclusion criteria: 1.patients diagnosed clinically or by rt-pcr in nasopharyngeal swab specimens and/ or lung involvement confirm by computed tomography scan compatible with covid-19patients 2.age between 18 year and 70 years, 3.body weight \> 50 kg, 4.with written informed consent from patients or relatives. - exclusion criteria 1 sensitivity to any medications of regimens, 2.e gfr less than 30. 3.pregnancy. 4.malignancy . 5.participating in another clinical study and refusing to participate in the study at a later date or later, and they are already taking colchicine for other diseases . -

May 3, 2021, 9:44 a.m. usa

inclusion criteria: 1.patients diagnosed clinically or by rt-pcr in nasopharyngeal swab specimens and/ or lung involvement confirm by computed tomography scan compatible with covid-19patients 2.age between 18 year and 70 years, 3.body weight > 50 kg, 4.with written informed consent from patients or relatives. - exclusion criteria 1 sensitivity to any medications of regimens, 2.e gfr less than 30. 3.pregnancy. 4.malignancy . 5.participating in another clinical study and refusing to participate in the study at a later date or later, and they are already taking colchicine for other diseases . -

inclusion criteria: 1.patients diagnosed clinically or by rt-pcr in nasopharyngeal swab specimens and/ or lung involvement confirm by computed tomography scan compatible with covid-19patients 2.age between 18 year and 70 years, 3.body weight > 50 kg, 4.with written informed consent from patients or relatives. - exclusion criteria 1 sensitivity to any medications of regimens, 2.e gfr less than 30. 3.pregnancy. 4.malignancy . 5.participating in another clinical study and refusing to participate in the study at a later date or later, and they are already taking colchicine for other diseases . -